Sign in

CIK 0001583771

  • Non-accelerated filer
  • Smaller reporting company

Hepion Pharmaceuticals, Inc.

Sign in to watch
Tickers
HEPA CTRVP
Exchange
OTC
Industry
Pharmaceutical Preparations
FY end
Dec 31
Incorporated
DE
Entity type
Operating
EIN
462783806
Phone
+1 732-902-4000
Business address
34 SHREWSBURY AVE., SUITE 1D, RED BANK, NJ, 07701
Former names
ContraVir Pharmaceuticals, Inc.

Securities

  • HEPA Common stock OTC
  • CTRVP Common stock OTC
  1. 3 Insider Initial Statement of Ownership
  2. 4 Open-market buy Director bought 500,000 shares at $0.05 ($25,000)
  3. 4 Open-market buy Interim CEO bought 2,000,000 shares at $0.05 ($100,000)
  4. 4 Open-market buy Director bought 2,000,000 shares at $0.05 ($100,000)
  5. 4 Open-market buy Chief Operating Officer bought 2,000,000 shares at $0.05 ($100,000)
  6. 4 Open-market buy Executive Chairman bought 10,000,000 shares at $0.05 ($500,000)
  7. 3 Insider Initial Statement of Ownership
  8. 3 Insider Initial Statement of Ownership
  9. 3 Insider Initial Statement of Ownership
  10. 3 Insider Initial Statement of Ownership
  11. 4 Open-market buy Director bought 1,250,000 shares at $0.04 ($50,000)
  12. 4 Open-market buy Executive Chairman bought 6,250,000 shares at $0.04 ($250,000)
  13. 4 Open-market buy Director bought 1,250,000 shares at $0.04 ($50,000)
  14. 4 Open-market buy Interim CEO bought 1,250,000 shares at $0.04 ($50,000)
  15. 3 Insider Initial Statement of Ownership
  16. 3 Insider Initial Statement of Ownership
  17. 3 Insider Initial Statement of Ownership
  18. 4 Derivatives Options or other derivatives
  19. 3 Insider Initial Statement of Ownership
  20. 4 Derivatives Options or other derivatives

Page 2 of 8 · 158 filings